1. Home
  2. NVAX vs LMAT Comparison

NVAX vs LMAT Comparison

Compare NVAX & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.80

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$83.79

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
LMAT
Founded
1987
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.9B
IPO Year
1995
2006

Fundamental Metrics

Financial Performance
Metric
NVAX
LMAT
Price
$6.80
$83.79
Analyst Decision
Hold
Buy
Analyst Count
8
6
Target Price
$9.75
$101.83
AVG Volume (30 Days)
3.3M
214.7K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
0.95%
EPS Growth
N/A
27.40
EPS
2.07
2.32
Revenue
$1,064,651,000.00
$240,866,000.00
Revenue This Year
$58.91
$15.17
Revenue Next Year
N/A
$9.07
P/E Ratio
$3.33
$36.43
Revenue Growth
20.27
13.07
52 Week Low
$5.01
$71.42
52 Week High
$11.55
$105.55

Technical Indicators

Market Signals
Indicator
NVAX
LMAT
Relative Strength Index (RSI) 47.44 45.65
Support Level $6.36 $82.52
Resistance Level $6.98 $88.28
Average True Range (ATR) 0.22 2.38
MACD 0.06 0.23
Stochastic Oscillator 64.44 26.30

Price Performance

Historical Comparison
NVAX
LMAT

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

Share on Social Networks: